The therapeutic potential of the calpain family: new aspects

Maria E. Saez, Reposo Ramirez-Lorca, Francisco J. Moron, Agustin Ruiz

Research output: Contribution to journalReview articlepeer-review

106 Scopus citations

Abstract

The calpain family is a group of cysteine proteases unique in their dependency on calcium to attain functionally active forms. Calpains are involved in a wide range of cellular calcium-regulated functions, including signal transduction, cell proliferation and differentiation, and apoptosis. Moreover, altered calpain activity has been observed in several human diseases. Specific calpain inhibitors hold promise for the treatment of neuromuscular and neurodegenerative diseases in which calpains have been shown to be upregulated (e.g. Parkinson's disease and Duchenne muscular dystrophy). Conversely, calpain activators could be a useful approach for those diseases where reduced calpain activity has been observed, such as type 2 diabetes or metabolic syndrome.

Original languageEnglish (US)
Pages (from-to)917-923
Number of pages7
JournalDrug Discovery Today
Volume11
Issue number19-20
DOIs
StatePublished - Oct 2006
Externally publishedYes

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery

Fingerprint

Dive into the research topics of 'The therapeutic potential of the calpain family: new aspects'. Together they form a unique fingerprint.

Cite this